XLV week 1: first confirmation positive, but conviction still low
State Street Health Care Select Sector SPDR ETF at week 1 of a confirmed buy signal. Signal strength is medium-weak (38 out of 100) with a low-volatility profile: a steady start, not a strong launch. First management window at week 6.
XLU at Week 3 of Observation: The Decline Has Not Yet Been Confirmed
XLU is at week 3 of a sell signal observation that has yet to confirm. The picture is mixed: negative weekly MACD, but a daily double bottom and trading not recommended. Discipline calls for waiting.
XLRE: 2 of 3 targets hit at week 8, risk now zeroed out
XLRE is at week 8 of a buy trade with 2 of 3 model targets already hit and a breakeven stop in place. Risk is zeroed out; the final window toward week 10 remains open, with the real estate sector still in a strength phase.
XLP Week 2: Weak Confirmation, Trade Holds but Conviction Remains Low
XLP is in its 2nd week of a buy signal. The confirmation week closed bearish and signal strength stands at 29 out of 100: weak conviction, but a steady volatility profile and a double bottom in the 82 area provide visible technical support.
XLK at week 8: two targets hit, breakeven stop, time to manage
At week 7 of the buy signal on XLK, 2 of the 3 model targets have already been reached and the stop has moved to breakeven. The next management window is week 8: discipline suggests trimming 20% of the position.
XLI at the second window: the signal holds but strength is nearly gone
At week 7, the buy signal on XLI holds but strength has dropped to 26 out of 100. The first model reference is already hit; the week-8 window to trim 20% is approaching.